IDO1 and neoplasm: In the TME it can promote tumor cell apoptosis and activate cellular immunity but can also upregulate inhibitory molecules, such as PD-L1, PD-L2, indoleamine 2,3-dioxygenase 1 (IDO), FAS, and FAS ligand (FASL) 64.